Tokyo, Japan

Jyun Isayama

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Nitto-Denko Corporation. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jyun Isayama. Retrieved from https://idiyas.com/inventor/jyun-isayama

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jyun Isayama: Innovator in Pharmaceutical Composition

Introduction

Jyun Isayama is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that enhance the stability of active ingredients.

Latest Patents

Isayama holds a patent for a production method of a pregabalin-containing composition. This innovative method suppresses the crystallization of pregabalin, which is crucial for maintaining the efficacy of the drug. The patent outlines a systematic approach to producing a pregabalin-containing composition that demonstrates reduced crystallization, thereby improving its overall performance.

Career Highlights

Throughout his career, Jyun Isayama has worked with prominent companies such as Nitto Denko Corporation and JSR Corporation. His experience in these organizations has allowed him to refine his skills and contribute to advancements in pharmaceutical technologies.

Collaborations

Isayama has collaborated with talented individuals in his field, including Chie Matsumoto and Tomohito Takita. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.

Conclusion

Jyun Isayama's work in the pharmaceutical industry exemplifies the impact of innovative thinking on drug formulation. His contributions, particularly in the area of pregabalin compositions, highlight the importance of stability in pharmaceutical products.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…